Brand-name drug prices have been increasing faster than the rate of general inflation for decades.
These lifetime price increases often greatly exceeded the corresponding rate of general inflation.
Prices for Top Medicare Part D Drugs Have Nearly Doubled Since Entering the Market
This Spotlight highlights the importance of the drug pricing-related provisions in the 2022 Inflation Reduction Act by examining how the prices of 25 top Part D drugs have changed since each product entered the market.
